GleamWall
中文EN

BCYC BICYCLE THERAPEUTICS PLC

Pharmaceutical Preparations · Nasdaq · SEC CIK 1761612 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY194.7%
TTM net income YoY43.4%
TTM EPS YoY43.9%
Revenue 3-yr CAGR49.8%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-189.4%
Net margin-169.8%
FCF margin-211.9%
EBITDA margin-183.8%

Returns

ROE-25.2%
ROA-21.3%
ROIC (approx.)-4,542.9%
Asset turnover0.13x

Leverage & solvency

Liabilities / assets10.9%
Debt / equity0.00x
Current ratio12.09x
Interest coverage-815.60x

Cash quality & payout

Operating cash flow / net income1.24x
Accruals ratio5.0%
Payout ratio—
Capex / revenue2.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$72.59M$35.27M
R&D expense$240.28M$172.97M
SG&A expense$79.37M$72.18M
Operating income-$247.06M-$209.87M
Interest expense$206,000$1.73M
Pretax income-$218.81M-$173.80M
Income tax$152,000-$4.76M
Net income-$218.96M-$169.03M
EBITDA-$240.64M-$202.70M
EPS (basic)-3.16-2.90
EPS (diluted)-3.16-2.90
Dividends declared per share0.000.00
Weighted avg. shares (diluted)69.28M58.21M
Balance sheet
Cash & equivalents$628.11M$880.07M
Receivables$0$0
Current assets$682.88M$928.61M
PP&E, net$6.02M$9.52M
Total assets$717.60M$956.87M
Current liabilities$56.98M$67.23M
Total liabilities$107.62M$163.81M
Shareholders' equity$609.98M$793.06M
Shares outstanding69.37M69.06M
Cash flow statement
Operating cash flow-$249.68M-$164.72M
Capital expenditure$2.35M$1.24M
Free cash flow-$252.03M-$165.96M
Investing cash flow-$2.35M-$1.24M
Financing cash flow-$131,000$519.75M
Depreciation & amortization$6.42M$7.17M
Stock-based compensation$39.46M$38.08M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.